Correlation Between GlaxoSmithKline PLC and HUDSON GLOBAL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and HUDSON GLOBAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and HUDSON GLOBAL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and HUDSON GLOBAL INCDL 001, you can compare the effects of market volatilities on GlaxoSmithKline PLC and HUDSON GLOBAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of HUDSON GLOBAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and HUDSON GLOBAL.

Diversification Opportunities for GlaxoSmithKline PLC and HUDSON GLOBAL

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between GlaxoSmithKline and HUDSON is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and HUDSON GLOBAL INCDL 001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUDSON GLOBAL INCDL and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with HUDSON GLOBAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUDSON GLOBAL INCDL has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and HUDSON GLOBAL go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and HUDSON GLOBAL

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.25 times more return on investment than HUDSON GLOBAL. However, GlaxoSmithKline PLC ADR is 4.04 times less risky than HUDSON GLOBAL. It trades about 0.01 of its potential returns per unit of risk. HUDSON GLOBAL INCDL 001 is currently generating about 0.0 per unit of risk. If you would invest  3,251  in GlaxoSmithKline PLC ADR on August 26, 2024 and sell it today you would earn a total of  145.00  from holding GlaxoSmithKline PLC ADR or generate 4.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.22%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  HUDSON GLOBAL INCDL 001

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
HUDSON GLOBAL INCDL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUDSON GLOBAL INCDL 001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

GlaxoSmithKline PLC and HUDSON GLOBAL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and HUDSON GLOBAL

The main advantage of trading using opposite GlaxoSmithKline PLC and HUDSON GLOBAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, HUDSON GLOBAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUDSON GLOBAL will offset losses from the drop in HUDSON GLOBAL's long position.
The idea behind GlaxoSmithKline PLC ADR and HUDSON GLOBAL INCDL 001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories